Vimarsana
Biggest News Aggregation in the World

Deepa Jeyakumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deepa Jeyakumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deepa Jeyakumar Today - Breaking & Trending Today

Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients - Vimarsana News

Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5 years on an alternate regimen of dasatinib and blinatumomab.